Professional Documents
Culture Documents
prevents aging
The first Anti-RCS Protects DNA from Detoxifies
active in cosmetics UVA-induced damage cutaneous cells
Description Properties
GHK tripeptide stabilised within the tertiary Prevention and protection of the skin from
restructure structure of the vegetal protein, is able to extrinsic and intrinsic agents which cause
detoxify the skin from the noxius Reactive premature aging.
Carbonyl Species (RCS) and protects the skin
from photoaging. Applications
anti-radical aldenine can be incorporated in daily cosmetic
Appearance formulations where prevention of photoaging
Translucent solution containing 0.1% Tripeptide-1 is desired, improving simultaneously the
(GHK). elasticity and firmness of the skin. Also suitable
for sun care products.
INCI
Water (Aqua), Hydrolyzed Wheat Protein, Dosage
Hydrolyzed Soy Protein, Xanthan Gum, 2-5 %
Tripeptide-1.
Please contact us for information on the preservative system. Solubility
Water soluble.
Science
aldenine is the first cosmetic active ingredient
that is able to capture noxius RCS, avoiding the
necrosis of the keratinocytes and the loss of
collagen elasticity. At the same time it protects
the skin from DNA damage induced by UV
radiation.
0
0 1 2
Time (h)
100
are effective indicators of protein
80
damage.
60
40
20
0
control 10 1 0.1 0.01
GHK (mg/ml)
The inactivation of SOD by its reaction with fructose is used as a model of glycation.
The increase in Collagen III can be seen even after 24 hours but a dose
dependent result is obtained after 7 days.
While the claims and supporting data provided in this publication are believed to be reliable and they are presented free and for guidance only, there are
no warranties of any kind. All express and implied warranties are disclaimed. The recipient is solely responsible for ensuring that products marketed to
consumers comply with all relevant laws and regulation. LIPOTEC is the exclusive holder of the both industrial and intellectual property rights identified
herein. Recipient of this publication agrees to indemnify and hold harmless each entity of the LIPOTEC organization for any and all regulatory action arising
from recipients use of any claims or information in this publication, including, but not limited to, use in advertising and finished product label claims, and
not present this publication as evidence of finished product claim substantiation to any regulatory authority.
Isaac Peral 17. Pol. Industrial Cam Ral - 08850 Gav (Barcelona) Spain - Tel +34 93 638 80 00 / Fax +34 93 638 93 93 - commercial@lipotec.com
Ed.9B